# Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN)

> **NCT03062813** · PHASE4 · UNKNOWN · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 112 (estimated)

## Conditions studied

- Hepatitis B Virus Associated Nephrotic Syndrome

## Interventions

- **DRUG:** Tacrolimus &entecavir
- **DRUG:** placebo & entecavir

## Key facts

- **NCT ID:** NCT03062813
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-01
- **Primary completion:** 2020-02-01
- **Final completion:** 2020-03-31
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2017-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062813, "Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03062813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*